- ZS Pharma (NASDAQ:ZSPH) has resumed trading and is up 6.7% after hours following a post-close news halt.
- The shares had moved up 28.4% today on takeover speculation; the company confirmed that it began some early talks regarding a "strategic transaction" with Actelion Pharmaceuticals.
- A purchase by Switzerland-based Actelion could value ZS at $2.5B, Bloomberg has reported. Market cap closed around $1.46B today.